A new Die Ophthalmologie review explains ELZA-sub400 cross-linking, an individualised protocol that fits the UV dose to each cornea, making cross-linking possible in keratoconus corneas as thin as 214 µm.
ELZA researchers report 12-month outcomes for a second-generation sub400 cross-linking protocol that extends CXL to ultra-thin keratoconus and post-LASIK ectasia corneas below 400 micrometres, halting progression in 76% of eyes while shortening treatment to about 18 minutes.
New CXL research challenges the role of oxygen in corneal cross-linking. Can oxygen-independent CXL improve keratoconus treatment? Find out how this breakthrough could change clinical practice.
